Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase

Autor: Phillip M. Pelphrey, Adrienne E. Smith, Jennifer M. Beierlein, Dennis L. Wright, Nigel D. Priestley, Amy C. Anderson, Tammy M. Joska, David B. Bolstad, Kathleen M. Frey
Rok vydání: 2008
Předmět:
Zdroj: Journal of Medicinal Chemistry. 51:7532-7540
ISSN: 1520-4804
0022-2623
DOI: 10.1021/jm800776a
Popis: Bacillus anthracis, the causative agent of anthrax, poses a significant biodefense danger. Serious limitations in approved therapeutics and the generation of resistance have produced a compelling need for new therapeutic agents against this organism. Bacillus anthracis is known to be insensitive to the clinically used antifolate, trimethoprim, because of a lack of potency against the dihydrofolate reductase enzyme. Herein, we describe a novel lead series of B. anthracis dihydrofolate reductase inhibitors characterized by an extended trimethoprim-like scaffold. The best lead compound adds only 22 Da to the molecular weight and is 82-fold more potent than trimethoprim. An X-ray crystal structure of this lead compound bound to B. anthracis dihydrofolate reductase in the presence of NADPH was determined to 2.25 Å resolution. The structure reveals several features that can be exploited for further development of this lead series.
Databáze: OpenAIRE